Event > Conference >
MPS World Summit 2025
40+ international organizations and companies participate in annual MPS World Summits to present the latest scientific achievements, discuss the advances and challenges, and enable communication between newly interested scientists and pioneers of the MPS field.
In 2025, the MPS World Summit will be in Brussels, Belgium. Join us to find out what’s new from CN Bio, including a new contract research service which launches on June 10th at the event, plus four posters showcasing our latest MPS advancements.
Visit us at MPS!
Our dedicated team of creative problem solvers will be available to answer questions and share over a decade of MPS expertise with you!
We look forward to meeting you to discuss how our PhysioMimix® range of products and services can help to improve the predictivity of your workflows and address your current workflow limitations – such as modelling the immune system in vitro and testing the safety of new modality drugs following the recent FDA announcement.
Get familiar with our human-relevant single- and multi-organ in vitro models/ assays/ all-in-one kits and contract research services.
Learn more about their proven track record for delivering clinically translatable results from our experts.
And discover our NEW Contract Research Service, launching on the 10th June!
Meet the newest product in our PhysioMimix range
With the all-in-one PhysioMimix DILI assay kit, Human 24, you can now easily recreate our FDA-recognised assay in your own lab for robust, reliable, human–relevant results.
- Unlock deep mechanistic insights beyond intrinsic DILI predictions
- Identify unique complex, latent, and immune-related events
- Proven solution refined through years of industry collaboration
- Minimize reliance on animals and decrease hepatotoxicity risk
Discover the latest MPS advancements at our poster presentations
Our Team at the MPS World Summit
Atefeh
Dr Atefeh Mobasseri, Field Application Scientist at CN Bio, has an extensive background in tissue engineering and regenerative medicine. Before joining CN Bio, she gained a PhD in Biomedical materials from the University of Manchester and carried out postdoctoral roles at the University of Manchester and Kings College London investigating the interaction, and effect, of 3D scaffolds on cellular behaviour. Since joining CN Bio, she has been supporting their European customers in using CN Bio’s range of PhysioMimix® systems to generate high content, human-relevant, data.
Adrian
A seasoned business developer with extensive commercial experience in the life science sector, Adrian Rea joined CN Bio as the European Director of Sales in June 2022. He brings valuable experience in the 3D cell culture market from his most recent role at InSphero, where he was responsible for developing business opportunities in European and Asian markets. He was previously Sales Director at Enzo Life Sciences, where he managed the restructuring of the global distributor sales channels and expanding the European sales operations. Adrian graduated from the University of Glasgow and received his PhD in pharmacology from Glasgow Caledonian University.
Oli
Oliver is a Senior Scientist at CN Bio where his work focuses on modelling MASH in the PhysioMimix MPS system. Oliver completed a BSc (Hons) Biomedical Sciences at University of Manchester and a PhD in Cell Biology at King’s College London, before undertaking postdoctoral work in Bioengineering at Queen Mary University of London. With over 15 years’ experience in academia and industry, Oliver’s background is in Cell and Molecular Biology with a focus on high-content imaging and in vitro assay design.
Yassen
Dr. Yassen Abbas is a Lead Scientist at CN Bio. He completed an MEng in chemical engineering at The University of Edinburgh and joined the European Space Agency as a graduate engineer. He later received a PhD from the University of Cambridge and completed a postdoc fellowship, also at Cambridge on the development of a tissue engineered model of the human endometrium. He has experience with real-time sensor technology, organoids and development of in vitro tissue models using human primary cells. Dr Abbas has published five peer-reviewed scientific articles, four as first author.
Sung
A seasoned life science professional with over 20 years of experience in product management, product marketing, and commercial leadership, Sung Lee joined CN Bio as a Director of Product Management in October 2024. He brings valuable experience in the assay kit market from his most recent role at Abcam, where he was the global lead as the senior product director for the Assay Kits and Protein product portfolio. He has held various leadership roles at renowned companies like Abcam (Danaher Company), Epitomics (‘The Rabbit Monoclonal Company’), and Life Technologies (Thermo Fisher Scientific). Sung’s education background includes business certifications from Cambridge Judge Business School and Wharton Business School, and a degree in Molecular and Developmental Biology from the University of California, Santa Cruz.
Justina
Justina is a Senior Scientist at CN Bio, focussing on liver toxicology within the R&D team. Her academic foundation includes a PhD in Experimental Medicine and Rheumatology and postdoctoral work at the William Harvey Research Institute (QMUL), where she spent her time investigating the potential of nanotechnology for drug development in rheumatoid arthritis, and synovial fibroblasts. With 9 years in academia and 3 years in industry, she brings a wealth of expertise to advancing biological research and practical applications.